Invesaro

Stocks Health care IXHL

NASDAQ · Health care

Incannex Healthcare Inc. (IXHL)

Incannex Healthcare Inc. reported revenue of $0 in fiscal 2026, down 100.0% from a year earlier. It posted a net loss of $19.3M. In fiscal 2026 capital spending exceeded operating cash flow by $12.9M. At June 30, 2026 it held $67.7M in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on September 25, 2026.

Free, no password. An email when IXHL files with the SEC.

Price
$2.19
-2.23% on the day · November 9, 2026
52-week range $2.16 to $14.91
Market cap
$26.2M
Revenue (FY2026)
$0
-100.0% year on year

Key facts about Incannex Healthcare Inc.

Net worth
Incannex Healthcare Inc. has a market value (market cap) of $26.2M at the latest share price, and shareholders' equity of $67.4M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2026 revenue was $0 (-100.0% year on year), with a net loss of $19.3M.
Cash flow
In fiscal 2026 operations used $12.9M of cash.
Latest report
The latest periodic report (annual report, 10-K) was filed with the SEC on September 25, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Incannex Healthcare Inc.'s next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Incannex Healthcare Inc. does

Incannex Healthcare Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker IXHL.

Revenue and profit by year

Revenue
FY20: $604.9K $604.9K FY20FY22: $1.9M $1.9M FY22FY24: $12K $12K FY24FY25: $86K $86K FY25FY26: $0 $0 FY26
Net income
FY20: -$4.7M -$4.7M FY20FY22: -$11.4M -$11.4M FY22FY22: -$14.9M -$14.9M FY22FY23: -$48.8M -$48.8M FY23FY24: -$18.5M -$18.5M FY24FY25: -$46.9M -$46.9M FY25FY26: -$19.3M -$19.3M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$0-$23M-$19.3M-$1.66-$12.9M
2025$86K-$23.8M-$46.9M-$40.82-$12.5M
2024$12K-$30M-$18.5M-$34.77-$16.1M
2023n/a-$49.7M-$48.8M-$100.39-$11.1M
2022n/an/a-$14.9M-$96.53n/a
2022$1.9Mn/a-$11.4M-$89.58n/a

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 13, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 14, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Latest SEC filings

What Incannex Healthcare Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 25, 2026
    Annual report10-K · period to June 30, 2026Incannex Healthcare narrowed its net loss and increased its cash reserves to fund operations for at least twelve months.Diluted EPS -$1.66 versus -$40.82.
  2. September 9, 2026
  3. August 25, 2026
  4. August 14, 2026
  5. August 11, 2026
  6. July 23, 2026
  7. June 25, 2026
  8. June 10, 2026
  9. June 9, 2026
  10. May 15, 2026
    Quarterly report 10-Q · period to March 31, 2026Diluted EPS -$0.35 versus -$6.19.

Recent insider filings (Forms 3, 4 and 144): 6, the latest on November 14, 2025. Insider transactions on SEC

Insider trades

What the people running Incannex Healthcare Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
November 14, 2025 Anastassov GeorgeDirector Received as pay 1,686,956 - - Form 4
November 14, 2025 Latham JoelCEO and President, Director Received as pay 22,608,692 - - Form 4
November 14, 2025 Swan JosephCFO, Treasurer and Secretary Received as pay 869,565 - - Form 4
November 14, 2025 Widdows PeterDirector Received as pay 1,686,956 - - Form 4
November 14, 2025 Clark RobertDirector Received as pay 1,686,956 - - Form 4
November 14, 2025 Valentine TroyDirector Received as pay 11,302,608 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns IXHL

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Polar Asset Management Partners Inc.13G, passive 7% 900,000 August 14, 2026

Latest filings below 5%: L1 Capital Global Opportunities Master Fund, Ltd. 4.99% (May 15, 2025); S.H.N. Financial Investments Ltd. 0% (May 15, 2025).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 15 managers reported a position.

HolderSharesValueChange on quarter
LPL Financial LLC148,178$557.1K+77,000
Millennium Management LLC95,252$358.1Knew
Jane Street Group, LLC78,195$294Knew
AdvisorShares Investments LLC60,868$228.9K+36,365
Susquehanna International Group, Llp28,771$108.2Knew
Commonwealth Equity Services, LLC14,029$52.8K+1,917
Citadel Advisors LLC10,349$38.9Knew
Osaic Holdings, Inc.6,376$24K0
UBS Group AG3,610$13.6K-36,759
Morgan Stanley3,558$13.4K+1,493
Citigroup Inc2,814$10.6Knew
Quent Capital, LLC1,928$7.2K0
Barclays PLC750$2.8K0
Caitong International Asset Management Co., Ltd4$15new
Larson Financial Group LLC1$4-58

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

6 insiders reported holding 43,310,829 shares in total, about $94.9M at the last price.

HolderSharesAs of
Latham JoelCEO and President, Director 24,186,177 November 14, 2025
Valentine TroyDirector 12,001,858 November 14, 2025
Anastassov GeorgeDirector 2,456,677 November 14, 2025
Widdows PeterDirector 1,957,803 November 14, 2025
Clark RobertDirector 1,786,956 November 14, 2025
Swan JosephCFO, Treasurer and Secretary 921,358 November 14, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about IXHL

What does Incannex Healthcare Inc. do?

Incannex Healthcare Inc. is a company in the Health care sector, listed on NASDAQ as IXHL. Its shares trade on NASDAQ under the ticker IXHL.

What is Incannex Healthcare Inc.'s net worth?

Incannex Healthcare Inc. has a market value (market cap) of $26.2M at the latest share price, and shareholders' equity of $67.4M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Incannex Healthcare Inc. profitable?

No. In fiscal 2026 it reported a net loss of $19.3M.

How much revenue does Incannex Healthcare Inc. make?

In fiscal 2026 Incannex Healthcare Inc. reported revenue of $0. That is 100.0% less than a year earlier.

When did Incannex Healthcare Inc. last report?

Its most recent periodic report is the annual report (10-K) filed on September 25, 2026. It covers the period to June 30, 2026.

When is Incannex Healthcare Inc.'s next earnings report?

Incannex Healthcare Inc.'s next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare IXHL with

Compare IXHL with any company

Follow IXHL

Get an email when Incannex Healthcare Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when IXHL files with the SEC.

Where the numbers come from

Financial figures are the values Incannex Healthcare Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.